KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Twist Bioscience (TWST) Leases (2019 - 2026)

Twist Bioscience has reported Leases over the past 8 years, most recently at $70.7 million for Q1 2026.

  • Quarterly Leases rose 30.69% to $70.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $70.7 million through Mar 2026, up 30.69% year-over-year, with the annual reading at $49.4 million for FY2025, 16.07% down from the prior year.
  • Leases was $70.7 million for Q1 2026 at Twist Bioscience, down from $72.3 million in the prior quarter.
  • Over five years, Leases peaked at $78.2 million in Q1 2022 and troughed at $49.4 million in Q3 2025.
  • The 5-year median for Leases is $70.7 million (2026), against an average of $66.2 million.
  • Year-over-year, Leases soared 152.33% in 2022 and then fell 18.26% in 2024.
  • A 5-year view of Leases shows it stood at $73.8 million in 2022, then fell by 6.32% to $69.1 million in 2023, then fell by 18.26% to $56.5 million in 2024, then increased by 27.96% to $72.3 million in 2025, then decreased by 2.23% to $70.7 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Leases are $70.7 million (Q1 2026), $72.3 million (Q4 2025), and $49.4 million (Q3 2025).